Trauma-Informed Care for Quitting Smoking During Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help pregnant women quit smoking using a trauma-informed care approach. The researchers seek to determine if understanding and addressing past trauma can facilitate smoking cessation. The trial collaborates with healthcare professionals to develop and test a program that combines trauma-informed care (a supportive therapy approach) with an existing smoking cessation method. Women who are currently pregnant, have experienced trauma, and still smoke might be suitable candidates for this trial. Participants should be comfortable speaking English or Spanish.
As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance support for pregnant women trying to quit smoking.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this trauma-informed care approach is safe for pregnant women?
Previous studies have shown that trauma-informed care aids recovery from substance use disorders. This approach emphasizes understanding trauma and supporting recovery compassionately. Although specific safety data for trauma-informed care is lacking, it focuses on emotional and psychological support rather than medications or medical procedures, thus avoiding the risks associated with drug treatments.
The studies report no major negative effects linked to trauma-informed care itself, suggesting it is well-tolerated. It builds on existing practices like the 5As for quitting smoking, which are standard and safe methods used by healthcare providers. Given its nature, this type of care is likely safe for pregnant women seeking to quit smoking.12345Why are researchers excited about this trial?
Researchers are excited about trauma-informed care for quitting smoking during pregnancy because it offers a personalized approach that considers the emotional and psychological aspects of trauma. Unlike traditional smoking cessation methods, which often focus solely on behavioral changes or nicotine replacement therapies, trauma-informed care addresses the underlying trauma that may contribute to smoking habits. This approach fosters a supportive environment where pregnant individuals can better understand and manage their triggers, potentially leading to more effective and lasting results. By integrating trauma awareness into the care process, this method aims to empower individuals with greater self-awareness and coping strategies, which could significantly improve smoking cessation success rates during pregnancy.
What evidence suggests that trauma-informed care is effective for quitting smoking during pregnancy?
Studies have shown that trauma-informed care can aid recovery from substance use problems, such as smoking. This approach involves understanding how trauma affects individuals, recognizing its signs, and applying this knowledge in treatment. Research has also demonstrated that the 5As method—asking, advising, assessing, assisting, and arranging support—significantly helps pregnant women quit smoking. This trial will explore combining trauma-informed care with the 5As, which could be particularly beneficial for pregnant women with past trauma who wish to stop smoking. This combination has shown promise in helping them quit during pregnancy.24678
Who Is on the Research Team?
Anita Hargrave-Bouagnon, MD, MAS
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for pregnant women who smoke and have experienced trauma. It aims to help them quit smoking using a trauma-informed approach. Participants should be from racial and ethnic minoritized groups, primarily served by a public safety-net clinic in San Francisco.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Development and Pilot
Clinician- and patient-participants will participate in a 60-minute in-depth, semi-structured interview to assess barriers to smoking cessation and inform the design of the RISE Pregnancy intervention.
Follow-up
Participants are monitored for feedback and effectiveness of the intervention design.
What Are the Treatments Tested in This Trial?
Interventions
- Trauma-Informed Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Tobacco Related Disease Research Program
Collaborator